Assembly Biosciences (ASMB) Treasury Shares (2013 - 2025)
Assembly Biosciences (ASMB) posted quarterly Treasury Shares of $240832.0 for Q4 2025, up 361.17% year-over-year from $52222.0 in Q4 2024, and up 361.17% quarter-over-quarter from $52222.0 in Q4 2024.
Assembly Biosciences (ASMB) Treasury Shares (2013 - 2025) Analysis & Trends
Assembly Biosciences' Treasury Shares history runs 12 years deep, the most recent figure standing at $240832.0 for Q4 2025.
- In Q4 2025, Treasury Shares rose 361.17% year-over-year to $240832.0; the TTM figure through Dec 2025 stood at $240832.0 (up 361.17% YoY), while the FY2025 annual figure was $240832.0, up 361.17% from the prior year.
- Treasury Shares for Q4 2025 stood at $240832.0, up from $52222.0 in the prior quarter.
- The five-year high for Treasury Shares was $1.8 million in Q3 2022, with the low at $50000.0 in Q2 2022.
- The 5-year median for Treasury Shares is $747788.0 (2021), against an average of $693952.1.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares tumbled 93.31% in 2022, then jumped 361.17% in 2025.
- Assembly Biosciences' Treasury Shares stood at $970339.0 in 2021, then slumped by 85.41% to $141544.0 in 2022, then sank by 32.75% to $95182.0 in 2023, then slumped by 45.13% to $52222.0 in 2024, then surged by 361.17% to $240832.0 in 2025.
- Business Quant data shows ASMB's Treasury Shares at $240832.0 in Q4 2025, $52222.0 in Q4 2024, and $95182.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 240,832.00 |
| Dec 31, 2025 | 240,832.00 |
| Dec 31, 2024 | 52,222.00 |
| Dec 31, 2024 | 52,222.00 |
| Dec 31, 2023 | 95,182.00 |
| Dec 31, 2023 | 95,182.00 |
| Dec 31, 2022 | 141,544.00 |
| Dec 31, 2022 | 141,544.00 |
| Sep 30, 2022 | 1.84 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2022 | 1.55 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 970,339.00 |
| Dec 31, 2021 | 970,339.00 |
| Sep 30, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 747,788.00 |
| Jun 30, 2021 | 747,788.00 |